Wellington Management Group’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.91M Buy
695,848
+54,670
+9% +$173K ﹤0.01% 1561
2025
Q4
$2.37M Sell
641,178
-40,116
-6% -$130K ﹤0.01% 1558
2025
Q3
$1.81M Buy
+681,294
New +$1.32M ﹤0.01% 1658
2025
Q2
Sell
-761,980
Closed -$1.1M 1976
2025
Q1
$1.1M Buy
761,980
+201,704
+36% +$372K ﹤0.01% 1688
2024
Q4
$1.23M Sell
560,276
-42,660
-7% -$99.5K ﹤0.01% 1681
2024
Q3
$995K Buy
602,936
+241,512
+67% +$488K ﹤0.01% 1710
2024
Q2
$802K Buy
361,424
+597
+0.2% +$1.4K ﹤0.01% 1716
2024
Q1
$967K Buy
+360,827
New +$877K ﹤0.01% 1695
2023
Q2
Sell
-236,874
Closed -$377K 1865
2023
Q1
$377K Sell
236,874
-8,200
-3% -$42.3K ﹤0.01% 1883
2022
Q4
$1.53M Sell
245,074
-29,351
-11% -$210K ﹤0.01% 1558
2022
Q3
$1.84M Sell
274,425
-18,353
-6% -$126K ﹤0.01% 1541
2022
Q2
$1.86M Hold
292,778
﹤0.01% 1555
2022
Q1
$1.36M Buy
292,778
+74,458
+34% +$319K ﹤0.01% 1681
2021
Q4
$1.09M Buy
+218,320
New +$1.75M ﹤0.01% 1784
2020
Q1
Sell
-10,773
Closed -$642K 1951
2019
Q4
$642K Buy
+10,773
New +$484K ﹤0.01% 1808
2019
Q3
Sell
-15,296
Closed -$712K 2039
2019
Q2
$712K Hold
15,296
﹤0.01% 1841
2019
Q1
$614K Sell
15,296
-2,683
-15% -$120K ﹤0.01% 1864
2018
Q4
$827K Buy
+17,979
New +$866K ﹤0.01% 1834
2018
Q3
Sell
-12,935
Closed -$507K 2236
2018
Q2
$507K Sell
12,935
-62,934
-83% -$3.18M ﹤0.01% 2038
2018
Q1
$5.49M Buy
75,869
+47,908
+171% +$3.52M ﹤0.01% 1452
2017
Q4
$1.84M Sell
27,961
-3,198
-10% -$172K ﹤0.01% 1767
2017
Q3
$1.56M Buy
31,159
+22,783
+272% +$1.1M ﹤0.01% 1774
2017
Q2
$388K Buy
+8,376
New +$308K ﹤0.01% 2073
2015
Q2
Sell
-2,730
Closed -$253K 2164
2015
Q1
$253K Buy
+2,730
New +$176K ﹤0.01% 2103

Other funds holding ESPR